Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.320
-0.020 (-5.91%)
Nov 21, 2024, 11:55 AM EST - Market open
Klotho Neurosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2011 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '11 Dec 31, 2011 |
Net Income | -4.21 | -0.71 | -0.6 | -1.11 | -0.91 | -0.52 | |
Stock-Based Compensation | 1.89 | - | 0 | 0.82 | 0.75 | - | |
Other Operating Activities | 0.25 | - | - | - | - | 0.25 | |
Change in Accounts Payable | -0.05 | 0.1 | 0 | -0.01 | - | - | |
Change in Other Net Operating Assets | 0.46 | 0.13 | -0.01 | 0.02 | - | - | |
Operating Cash Flow | -2.23 | -0.47 | -0.6 | -0.28 | -0.17 | -0.27 | |
Sale (Purchase) of Intangibles | -0.02 | 0.02 | -0.13 | - | - | - | |
Investing Cash Flow | -0.02 | 0.02 | -0.13 | - | - | - | |
Long-Term Debt Issued | - | 0.02 | - | - | - | - | |
Net Debt Issued (Repaid) | 1.12 | 0.02 | - | - | - | - | |
Issuance of Common Stock | 0.4 | 0.1 | 0.75 | 0.25 | 0.5 | 0.56 | |
Other Financing Activities | 0.78 | 0.25 | -0.25 | - | - | -0.29 | |
Financing Cash Flow | 2.3 | 0.37 | 0.5 | 0.25 | 0.5 | 0.27 | |
Net Cash Flow | 0.05 | -0.07 | -0.22 | -0.03 | 0.33 | 0 | |
Free Cash Flow | -2.23 | -0.47 | -0.6 | -0.28 | -0.17 | -0.27 | |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | - | - | |
Cash Interest Paid | 0.08 | 0.08 | 0.02 | - | - | - | |
Levered Free Cash Flow | -1.81 | 0.11 | -0.75 | - | - | - | |
Unlevered Free Cash Flow | -1.76 | 0.16 | -0.74 | - | - | - | |
Change in Net Working Capital | -0.64 | -0.53 | 0.25 | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.